Zabbio, Inc.

Zabbio Inc. is a corporate, for-profit organization registered in SAM.gov, located in San Diego, California, with a focus on biotechnology and medical research development. The company appears to specialize in advanced medical therapeutic research, particularly in areas involving monoclonal antibodies and innovative pharmaceutical product development. While specific details about the company's full organizational background are limited in the provided documentation, the firm demonstrates significant expertise in developing complex medical interventions and collaborating with academic research institutions.

Zabbio Inc. has been awarded federal grants primarily in the biomedical research domain, with notable work in infectious disease and contraceptive technologies. The company's most recent significant federal grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), involves developing a monoclonal antibody therapy for treating neonatal herpes simplex virus infections, representing a sophisticated medical research project. Additionally, Zabbio has been involved in sub-grant work with prominent research institutions, including Boston University and Emory University, focusing on contraceptive development projects. These sub-grants have involved critical research activities such as overseeing drug substance manufacturing, conducting nonclinical studies, managing clinical trials, and handling regulatory interactions with the FDA. The company's grant work demonstrates a strong capability in pharmaceutical research, product development, and regulatory compliance across multiple complex medical research domains.